1-4 of 4
Authors: Jorge Hernando
Save search
Sort by
Journal Article

Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study

PDF
Maribel del Olmo-García and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae343, https://doi.org/10.1093/oncolo/oyae343
Published: 25 February 2025
Journal Article

Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial

PDF
Enrique Grande and others
The Oncologist, Volume 26, Issue 11, November 2021, Pages 941–949, https://doi.org/10.1002/onco.13885
Published: 14 July 2021
Journal Article

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?

PDF
Elettra Merola and others
The Oncologist, Volume 26, Issue 4, April 2021, Pages 294–301, https://doi.org/10.1002/onco.13633
Published: 29 December 2020
Journal Article

Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors

PDF
Jaume Capdevila and others
The Oncologist, Volume 24, Issue 12, December 2019, Pages e1315–e1320, https://doi.org/10.1634/theoncologist.2018-0675
Published: 22 July 2019